Early Phase 1 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older.
- People who have been diagnosed with breast cancer that is oestrogen receptor (ER) positive, confirmed by a laboratory test.
- People who have at least one tumour or lesion measuring 1.0 cm or larger that has been detected on a standard scan such as a mammogram, ultrasound, MRI, CT, or PET/CT scan.
- People who are willing to be informed about the research nature of this study and sign a written consent form before any study procedures begin.
Who may not be able to join:
- People who are pregnant or breastfeeding (a pregnancy test will be carried out before any imaging for women who could potentially become pregnant).
- People who, in the opinion of the study doctor or treating physician, would not be able to tolerate the imaging procedures involved in the study.
- People who are currently taking tamoxifen or raloxifene.
- People who have a medical condition, illness, or disorder that a study physician considers could put their safety at risk or prevent them from fully participating in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Christine Edmonds, MD, Abramson Cancer Center at Penn Medicine
Phone: 2155736569
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Uptake of FES on BPET; Image quality; Image artifacts; Parenchymal appearance; Tumor size and extent
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.